Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sandoz
Pharma
Sandoz has filed a lawsuit against Amgen and its Enbrel patents
Sandoz has filed an antitrust lawsuit in U.S. court claiming that Amgen has blocked competition to “unlawfully extend its monopoly” on Enbrel.
Kevin Dunleavy
Apr 14, 2025 11:20am
J&J sues Samsung Bioepis over Stelara biosimilar agreement
Feb 25, 2025 10:21am
Amgen fends off Celltrion's proposed Prolia biosim until June
Jan 28, 2025 11:46am
Sandoz shells out $275M in settlement over price-fixing claims
Dec 17, 2024 11:19am
Regeneron loses bid to block Amgen's Eylea biosim, sinking shares
Sep 24, 2024 10:32am
Sandoz, Liquidia score $137M win in United generic lawsuit
Sep 16, 2024 2:54pm
